GlaxoSmithKline ( GSK ) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug Administration (FDA) approval. Raxibacumab was approved for
Visit site:
Glaxo’s Anthrax Drug Gets FDA Nod – Analyst Blog
GlaxoSmithKline ( GSK ) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug Administration (FDA) approval. Raxibacumab was approved for
Visit site:
Glaxo’s Anthrax Drug Gets FDA Nod – Analyst Blog